Chinese Journal of Dermatology ›› 2026, e20250537.doi: 10.35541/cjd.20250537
• Guidelines and Consensus • Previous Articles
Chinese Society of Dermatology; China Dermatologist Association
Received:2025-09-28
Revised:2026-01-20
Online:2026-01-22
Published:2026-03-26
Contact:
Xiao Rong; Yang Bin; Gao Xinghua
CLC Number:
Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on the prevention, diagnosis, and treatment of nontuberculous mycobacterial skin infections associated with medical aesthetic procedures (2026 edition)[J]. Chinese Journal of Dermatology,2026,e20250537. doi:10.35541/cjd.20250537
| [1] | Tortoli E. Microbiological features and clinical relevance of new species of the genus Mycobacterium[J]. Clin Microbiol Rev, 2014,27(4):727⁃752. DOI: 10.1128/cmr.00035⁃14. |
| [2] | Johansen MD, Herrmann JL, Kremer L. Non⁃tuberculous mycobacteria and the rise of Mycobacterium abscessus[J]. Nat Rev Microbiol, 2020,18(7):392⁃407. DOI: 10.1038/s41579⁃020⁃0331⁃1. |
| [3] | Li Y, Zhang W, Zhao J, et al. Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes[J]. Emerg Microbes Infect, 2022,11(1):1973⁃1981. DOI: 10.1080/22221751. 2022.2103453. |
| [4] | Turenne CY. Nontuberculous mycobacteria: insights on taxonomy and evolution[J]. Infect Genet Evol, 2019,72:159⁃168. DOI: 10.1016/j.meegid.2019.01.017. |
| [5] | Ma X, Li XY, Liu JW. Demographic and clinical features of nontuberculous mycobacteria infection resulting from cosmetic procedures: a systematic review[J]. Int J Infect Dis, 2024,149:107259. DOI: 10.1016/j.ijid.2024.107259. |
| [6] | 中国疾病预防控制中心传染病预防控制所, 中国防痨协会人兽共患结核病专业分会. 分枝杆菌菌种中文译名专家共识[J]. 中国人兽共患病学报, 2023,39(3):205⁃220. DOI: 10. 3969/j.issn.1002⁃2694.2023.00.016. |
| [7] | Tortoli E, Fedrizzi T, Meehan CJ, et al. The new phylogeny of the genus Mycobacterium: the old and the news[J]. Infect Genet Evol, 2017,56:19⁃25. DOI: 10.1016/j.meegid.2017.10.013. |
| [8] | Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline[J]. Clin Infect Dis, 2020,71(4):e1⁃e36. DOI: 10.1093/cid/ciaa241. |
| [9] | Jabbour SF, Malek AE, Kechichian EG, et al. Nontuberculous mycobacterial infections after cosmetic procedures: a systematic review and management algorithm[J]. Dermatol Surg, 2020,46(1):116⁃121. DOI: 10.1097/dss.0000000000001929. |
| [10] | Zweijpfenning SMH, van Ingen J, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review[J]. Semin Respir Crit Care Med, 2018,39(3):336⁃342. DOI: 10.1055/s⁃0038⁃1660864. |
| [11] | Ren H, Xiao Y, Tang B, et al. The price of beauty: a literature review on non⁃tuberculous mycobacteria infection after cosmetic procedures[J]. Aesthet Surg J, 2024,44(8):NP574⁃NP584. DOI: 10.1093/asj/sjae076. |
| [12] | Daniau C, Lecorche E, Mougari F, et al. Association of healthcare and aesthetic procedures with infections caused by nontuberculous mycobacteria, France, 2012-2020[J]. Emerg Infect Dis, 2022,28(3):518⁃526. DOI: 10.3201/eid2803.211791. |
| [13] | Wu UI, Holland SM. Host susceptibility to non⁃tuberculous mycobacterial infections[J]. Lancet Infect Dis, 2015,15(8):968⁃980. DOI: 10.1016/s1473⁃3099(15)00089⁃4. |
| [14] | Bernut A, Nguyen⁃Chi M, Halloum I, et al. Mycobacterium abscessus⁃induced granuloma formation is strictly dependent on TNF signaling and neutrophil trafficking[J]. PLoS Pathog, 2016,12(11):e1005986. DOI: 10.1371/journal.ppat.1005986. |
| [15] | Qiang L, Zhang Y, Lei Z, et al. A mycobacterial effector promotes ferroptosis⁃dependent pathogenicity and dissemination[J]. Nat Commun, 2023,14(1):1430. DOI: 10.1038/s41467⁃023⁃37148⁃x. |
| [16] | Pajuelo D, Tak U, Zhang L, et al. Toxin secretion and trafficking by Mycobacterium tuberculosis[J]. Nat Commun, 2021,12(1):6592. DOI: 10.1038/s41467⁃021⁃26925⁃1. |
| [17] | Kotey SK, Tan X, Fleming O, et al. Intracellular iron accumulation facilitates mycobacterial infection in old mouse macrophages[J]. Geroscience, 2024,46(2):2739⁃2754. DOI: 10. 1007/s11357⁃023⁃01048⁃1. |
| [18] | Yamamoto K, Torigoe S, Kobayashi H. Formative evaluation and structural analysis of non⁃tuberculosis mycobacterial biofilm using material pieces[J]. Cell Surf, 2024,11:100125. DOI: 10.1016/j.tcsw.2024.100125. |
| [19] | Stienstra Y, van der Graaf WT, te Meerman GJ, et al. Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors[J]. Trop Med Int Health, 2001,6(7):554⁃562. DOI: 10.1046/j.1365⁃3156.2001.00746.x. |
| [20] | Yeo PM, Lee SX, Tan YE, et al. Epidemiology, risk factors, and outcomes of adult cutaneous non⁃tuberculous mycobacterial infection over a 10⁃year period in Singapore[J]. Int J Dermatol, 2019,58(6):679⁃687. DOI: 10.1111/ijd.14356. |
| [21] | Perera DJ, Koger⁃Pease C, Paulini K, et al. Beyond schistosomiasis: unraveling co⁃infections and altered immunity[J]. Clin Microbiol Rev, 2024,37(1):e0009823. DOI: 10.1128/cmr.00098⁃23. |
| [22] | Mortaz E, Moloudizargari M, Varahram M, et al. What immunological defects predispose to non⁃tuberculosis mycobacterial infections?[J]. Iran J Allergy Asthma Immunol, 2018,17(2):100⁃109. |
| [23] | Sergeant A, Conaglen P, Laurenson IF, et al. Mycobacterium chelonae infection: a complication of tattooing[J]. Clin Exp Dermatol, 2013,38(2):140⁃142. DOI: 10.1111/j.1365⁃2230. 2012.04421.x. |
| [24] | Curcó N, Prat C, Tarroch X, et al. Cutaneous infection in a tattoo due to Mycobacterium chelonae: a report of 2 cases and a review of the literature[J]. Actas Dermosifiliogr, 2012,103(9):840⁃843. DOI: 10.1016/j.ad.2012.01.019. |
| [25] | Tan LC, Li XY, Lu YG. Nontuberculous mycobacteria infection after autologous fat grafting for cosmetic breast augmentation[J]. Ann Plast Surg, 2020,85(4):358⁃362. DOI: 10.1097/sap.000 0000000002234. |
| [26] | Green DA, Whittier S, Greendyke W, et al. Outbreak of rapidly growing nontuberculous mycobacteria among patients undergoing cosmetic surgery in the dominican republic[J]. Ann Plast Surg, 2017,78(1):17⁃21. DOI: 10.1097/sap.0000000000000746. |
| [27] | Saunders KE, Reyes JM, Cyril L, et al. Notes from the field: nontuberculous mycobacteria infections after cosmetic surgery procedures in Florida ⁃ nine states, 2022⁃2023[J]. MMWR Morb Mortal Wkly Rep, 2024,73(3):66⁃67. DOI: 10.15585/mmwr.mm7303a4. |
| [28] | Llenas⁃García J, Vicente J, Ruiz⁃García MM, et al. A "lipo⁃tourist" with chronic cutaneous lesions after surgery in Ecuador: a diagnostic challenge[J]. Travel Med Infect Dis, 2018,25:77⁃78. DOI: 10.1016/j.tmaid.2018.07.013. |
| [29] | E Y, Hengshu Z. Clinical analysis of nontuberculous mycobacterial infection after minimally invasive plastic surgery and cosmetic surgery[J]. J Cosmet Dermatol, 2022,21(6):2523⁃2529. DOI: 10.1111/jocd.14395. |
| [30] | 余敏, 廖桂秀, 纪明开. 美容注射术后皮肤脓肿分枝杆菌感染临床分析[J]. 中国麻风皮肤病杂志, 2022,38(1):37⁃38. DOI: 10.12144/zgmfskin202201037. |
| [31] | Deng L, Luo YZ, Liu F, et al. Subcutaneous infection caused by Mycobacterium abscessus following cosmetic injections of botulinum toxin: a case report[J]. World J Clin Cases, 2022,10(18):6141⁃6147. DOI: 10.12998/wjcc.v10.i18.6141. |
| [32] | Hammond SE, Al⁃Bayati A, Joumblat N, et al. Mycobacterium chelonae infection of the buttocks secondary to lipofilling: a case report and review of the literature[J]. Aesthetic Plast Surg, 2017,41(5):1150⁃1154. DOI: 10.1007/s00266⁃017⁃0890⁃3. |
| [33] | Culton DA, Lachiewicz AM, Miller BA, et al. Nontuberculous mycobacterial infection after fractionated CO₂ laser resurfacing[J]. Emerg Infect Dis, 2013,19(3):365⁃370. DOI: 10.3201/eid1903.120880. |
| [34] | Berliner JG, Aldabagh B, Mully T, et al. Non⁃tuberculous mycobacterial infections following cosmetic laser procedures: a case report and review of the literature[J]. J Drugs Dermatol, 2015,14(1):80⁃83. |
| [35] | Eustace K, Jolliffe V, Sahota A, et al. Cutaneous Mycobacterium abscessus infection following hair transplant[J]. Clin Exp Dermatol, 2016,41(7):768⁃770. DOI: 10.1111/ced.12900. |
| [36] | Grubbs J, Bowen C. Mycobacterium abscessus infection following home dermabrasion[J]. Cutis, 2019,104(1):79⁃80. DOI: Not available. |
| [37] | Yeon J, Chan RC, Fallah H. Infection with Mycobacterium immunogenum following botulinum toxin injection[J]. Australas J Dermatol, 2021,62(1):79⁃80. DOI: 10.1111/ajd.13406. |
| [38] | Pennington KM, Vu A, Challener D, et al. Approach to the diagnosis and treatment of non⁃tuberculous mycobacterial disease[J]. J Clin Tuberc Other Mycobact Dis, 2021,24:100244. DOI: 10.1016/j.jctube.2021.100244. |
| [39] | Cowman S, van Ingen J, Griffith DE, et al. Non⁃tuberculous mycobacterial pulmonary disease[J]. Eur Respir J, 2019,54(1):1900250. DOI: 10.1183/13993003.00250⁃2019. |
| [40] | van Ingen J, Turenne CY, Tortoli E, et al. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review[J]. Int J Syst Evol Microbiol, 2018,68(11):3666⁃3677. DOI: 10.1099/ijsem.0.003026. |
| [41] | Yoshida M, Sano S, Chien JY, et al. A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility[J]. EBioMedicine, 2021,64:103187. DOI: 10.1016/j.ebiom.2020.103187. |
| [42] | 中国防痨协会非结核分枝杆菌病分会. 非结核分枝杆菌病分子生物学诊断专家共识. 中国防痨杂志, 2025,47(8):961⁃975. DOI: 10.19982/j.issn.1000⁃6621.20250225 |
| [43] | Buckwalter SP, Olson SL, Connelly BJ, et al. Evaluation of matrix⁃assisted laser desorption ionization⁃time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes[J]. J Clin Microbiol, 2016,54(2):376⁃384. DOI: 10.1128/jcm.02128⁃15. |
| [44] | Huang WC, Yu MC, Huang YW. Identification and drug susceptibility testing for nontuberculous mycobacteria[J]. J Formos Med Assoc, 2020,119 (Suppl 1):S32⁃S41. DOI: 10.1016/j.jfma.2020.05.002. |
| [45] | Brown⁃Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria[J]. J Clin Microbiol, 2019,57(10):e00834⁃19. DOI: 10.1128/jcm.00834⁃19. |
| [46] | Komm OD, Almeida DV, Converse PJ, et al. In vitro assessment of drug activity against Mycobacterium ulcerans[J]. Methods Mol Biol, 2022,2387:189⁃194. DOI: 10.1007/978⁃1⁃0716⁃1779⁃3_18. |
| [47] | Raveendran R, Oberoi JK, Wattal C. Multidrug⁃resistant pulmonary & extrapulmonary tuberculosis: a 13 years retrospective hospital⁃based analysis[J]. Indian J Med Res, 2015,142(5):575⁃582. DOI: 10.4103/0971⁃5916.171285. |
| [48] | Sarro YD, Kone B, Diarra B, et al. Simultaneous diagnosis of tuberculous and non⁃tuberculous mycobacterial diseases: time for a better patient management[J]. Clin Microbiol Infect Dis, 2018,3(3):10.15761/CMID.1000144. DOI: 10.15761/cmid.100 0144. |
| [49] | Hendrikx L, van Hees CLM, de Steenwinkel JEM, et al. Treatment and outcome of culture⁃confirmed Mycobacterium marinum disease[J]. Open Forum Infect Dis, 2022,9(4):ofac077. DOI: 10.1093/ofid/ofac077. |
| [50] | Seidel A, Nunes DH, Fernandes C, et al. Skin infection by Mycobacterium marinum ⁃ diagnostic and therapeutic challenge[J]. An Bras Dermatol, 2022,97(3):366⁃368. DOI: 10.1016/j.abd.2021.03.013. |
| [51] | Griffith DE, Aksamit T, Brown⁃Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007,175(4):367⁃416. DOI: 10.1164/rccm.200604⁃571ST. |
| [52] | Aubry A, Mougari F, Reibel F, et al. Mycobacterium marinum[J]. Microbiol Spectr, 2017,5(2):10.1128/microbiolspec.tnmi7⁃0038⁃2016. DOI: 10.1128/microbiolspec.TNMI7⁃0038⁃2016. |
| [53] | Bakuła Z, Modrzejewska M, Pennings L, et al. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium kansasii[J]. Antimicrob Agents Chemother, 2018,62(4):e01788⁃17. DOI: 10.1128/aac.01788⁃17. |
| [54] | Zhang M, Feng M, He JQ. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient[J]. Int J Infect Dis, 2017,62:59⁃63. DOI: 10.1016/j.ijid.2017. 07.006. |
| [55] | Moon SM, Choe J, Jhun BW, et al. Treatment with a macrolide⁃containing regimen for Mycobacterium kansasii pulmonary disease[J]. Respir Med, 2019,148:37⁃42. DOI: 10.1016/j.rmed.2019.01.012. |
| [56] | Lin S, Hua W, Wang S, et al. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates[J]. BMC Microbiol, 2022,22(1):175. DOI: 10.1186/s12866⁃022⁃02582⁃2. |
| [57] | Yao QH, Xia XJ, Xu JZ, et al. Primary cutaneous Mycobacteria avium complex infection in a systemic lupus erythematosus patient: a case report and review[J]. Medicine (Baltimore), 2025,104(6):e41450. DOI: 10.1097/md.0000000000041450. |
| [58] | Griffith DE, Eagle G, Thomson R, et al. Amikacin liposome inhalation suspension for treatment⁃refractory lung disease caused by Mycobacterium avium Complex (CONVERT). A prospective, open⁃label, randomized study[J]. Am J Respir Crit Care Med, 2018,198(12):1559⁃1569. DOI: 10.1164/rccm.201807⁃ 1318OC. |
| [59] | Saubolle MA, Kiehn TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans[J]. Clin Microbiol Rev, 1996,9(4):435⁃447. DOI: 10.1128/cmr.9.4.435. |
| [60] | 王洪生, 陈符, 许高, 等. 皮肤嗜血分枝杆菌感染二例研究[J]. 中华皮肤科杂志, 2015,48(10):679⁃682. |
| [61] | Nookeu P, Angkasekwinai N, Foongladda S, et al. Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum[J]. Emerg Infect Dis, 2019,25(9):1648⁃1652. DOI: 10.3201/eid2509.190430. |
| [62] | Wang XY, Jia QN, Li J. Treatment of non⁃tuberculosis mycobacteria skin infections[J]. Front Pharmacol, 2023,14:1242156. DOI: 10.3389/fphar.2023.1242156. |
| [63] | Chen Y, Jiang J, Jiang H, et al. Mycobacterium gordonae in patient with facial ulcers, nosebleeds, and positive T⁃SPOT.TB test, China[J]. Emerg Infect Dis, 2017,23(7):1204⁃1206. DOI: 10.3201/eid2307.162033. |
| [64] | Calado Nogueira de Moura V, Nguyen MH, Hunkins JJ, et al. In vitro susceptibility patterns for slowly growing non⁃tuberculous mycobacteria in the USA from 2018 to 2022[J]. J Antimicrob Chemother, 2023,78(12):2849⁃2858. DOI: 10.1093/jac/dkad317. |
| [65] | Kumar C, Shrivastava K, Singh A, et al. Skin and soft⁃tissue infections due to rapidly growing mycobacteria: an overview[J]. Int J Mycobacteriol, 2021,10(3):293⁃300. DOI: 10.4103/ijmy.ijmy_110_21. |
| [66] | Das S, Mishra B, Mohapatra PR, et al. Clinical presentations of nontuberculous mycobacteria as suspected and drug⁃resistant tuberculosis: experience from a tertiary care center in Eastern India[J]. Int J Mycobacteriol, 2022,11(2):167⁃174. DOI: 10. 4103/ijmy.ijmy_68_22. |
| [67] | Chung J, Ince D, Ford BA, et al. Cutaneous infections due to nontuberculosis Mycobacterium: recognition and management[J]. Am J Clin Dermatol, 2018,19(6):867⁃878. DOI: 10.1007/s40257⁃018⁃0382⁃5. |
| [68] | 中国"一带一路"皮肤病专病联盟分枝杆菌病研究联盟, 中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识(2024版)[J]. 中华皮肤科杂志, 2024,57(2):109⁃118. DOI: 10.35541/cjd.20230371. |
| [69] | Zhou J, Jia Q, Liu L, et al. Epidemiology and clinical outcomes in skin and soft tissue nontuberculous mycobacteria infections: a retrospective study[J]. J Infect Public Health, 2025,18(3):102655. DOI: 10.1016/j.jiph.2025.102655. |
| [70] | Nguyen TQ, Heo BE, Jeon S, et al. Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches[J]. Front Microbiol, 2024,15:1331508. DOI: 10.3389/fmicb.2024.1331508. |
| [71] | Tunesi S, Zelazny A, Awad Z, et al. Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra⁃pulmonary infections[J]. Clin Microbiol Infect, 2024,30(6):718⁃725. DOI: 10.1016/j.cmi.2023.09.019. |
| [72] | To K, Cao R, Yegiazaryan A, et al. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus[J]. J Clin Med, 2020,9(8):2541. DOI: 10.3390/jcm9082541. |
| [73] | Leto Barone AA, Grzelak MJ, Frost C, et al. Atypical mycobacterial infections after plastic surgery procedures abroad: a multidisciplinary algorithm for diagnosis and treatment[J]. Ann Plast Surg, 2020,84(3):257⁃262. DOI: 10.1097/sap.0000 000000002061. |
| [74] | 郭晶东, 陈波, 彭靓, 等. 美容手术相关非结核分枝杆菌感染的诊断和治疗方法[J]. 中华烧伤与创面修复杂志, 2024,40(7):673⁃678. DOI: 10.3760/cma.j.cn501225⁃20231031⁃00160. |
| [75] | 李丹, 王羽, 林威, 等. 美容术后并发非结核分枝杆菌感染治疗策略[J]. 中国医疗美容, 2022,12(7):24⁃28. DOI: 10.19593/j.issn.2095⁃0721.2022.07.007. |
| [76] | Sartelli M, Coccolini F, Kluger Y, et al. WSES/GAIS/WSIS/SIS⁃E/AAST global clinical pathways for patients with skin and soft tissue infections[J]. World J Emerg Surg, 2022,17(1):3. DOI: 10.1186/s13017⁃022⁃00406⁃2. |
| [77] | McClain SL, Bohan JG, Stevens DL. Advances in the medical management of skin and soft tissue infections[J]. BMJ, 2016,355:i6004. DOI: 10.1136/bmj.i6004. |
| [78] | 张晗, 刘文辉, 李广帅. 注射溶脂致非结核分枝杆菌感染11例临床分析[J]. 中国美容医学, 2023,32(5):79⁃82. DOI: 10.15909/j.cnki.cn61⁃1347/r.005664. |
| [79] | Schwartzman G, Khachemoune A. Surgical site infection after dermatologic procedures: critical reassessment of risk factors and reappraisal of rates and causes[J]. Am J Clin Dermatol, 2021,22(4):503⁃510. DOI: 10.1007/s40257⁃021⁃00599⁃3. |
| [80] | Blanc P, Dutronc H, Peuchant O, et al. Nontuberculous mycobacterial infections in a French hospital: a 12⁃year retrospective study[J]. PLoS One, 2016,11(12):e0168290. DOI: 10.1371/journal.pone.0168290. |
| [81] | Henkle E, Hedberg K, Schafer SD, et al. Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007⁃2012[J]. Emerg Infect Dis, 2017,23(10):1627⁃1630. DOI: 10.3201/eid2310.170845. |
| [82] | Nelson R. The growing trend of medical tourism[J]. Am J Nurs, 2017,117(7):18⁃19. DOI: 10.1097/01.NAJ.0000520937.93481.b7. |
| [83] | Pavli A, Maltezou HC. Infectious complications related to medical tourism[J]. J Travel Med, 2021,28(1):taaa210. DOI: 10.1093/jtm/taaa210. |
| [84] | Pereira RT, Malone CM, Flaherty GT. Aesthetic journeys: a review of cosmetic surgery tourism[J]. J Travel Med, 2018,25(1):tay051. DOI: 10.1093/jtm/tay042. |
| [85] | World Health Organization. Global guidelines for the prevention of surgical site infection[R]. Geneva: World Health Organization, 2018. |
| [86] | National Institute for Health Research Global Research Health Unit on Global Surgery. Delphi prioritization and development of global surgery guidelines for the prevention of surgical⁃site infection[J]. Br J Surg, 2020,107(8):970⁃977. DOI: 10.1002/bjs.11530. |
| [87] | Ling ML, Apisarnthanarak A, Abbas A, et al. APSIC guidelines for the prevention of surgical site infections[J]. Antimicrob Resist Infect Control, 2019,8:174. DOI: 10.1186/s13756⁃019⁃0638⁃8. |
| [1] | Ma Tongchuan, Deng Tingyue, Xiao Fengli. Associations between smoking and atopic dermatitis [J]. Chinese Journal of Dermatology, 2026, 59(6): 590-593. |
| [2] | Tian Jing, Song Zhiqiang. Application of tape stripping to the detection of biomarkers in atopic dermatitis [J]. Chinese Journal of Dermatology, 2026, 59(6): 578-581. |
| [3] | Pediatric Dermatology Group, Chinese Society of Dermatology, Dermatology Group, Chinese Pediatric Society, Chinese Medical Association, Pediatric Group, Chinese Association of Rehabilitation Dermatology, Atopic Dermatitis Group, Chinese Association of Rehabilitation Dermatology, Pediatric Dermatology Group, China Dermatologist Association, Dermatology Group, the Society of Pediatrics, Chinese Medical Doctor Association. Chinese consensus on the prevention, treatment, and management of atopic dermatitis in children(2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(6): 487-504. |
| [4] | Du Xinran, Wang Xinhe, Li Siyu, Chen Moan, Yuan Shaojie, Yan Ran, Cheng Linyan, Guo Wanjun, Wang Yi, Li Fulun. Development and evaluation of a diagnostic scale for atopic dermatitis with the syndrome of wind dryness due to blood deficiency [J]. Chinese Journal of Dermatology, 2026, 59(6): 540-546. |
| [5] | Zhang Hanyi, Guo Yeye, Xiao Yi, Chen Xiang, Su Juan. Role of chronic psychological stress-induced lipid metabolism dysregulation and immune microenvironment alterations in an atopic dermatitis-like mouse model [J]. Chinese Journal of Dermatology, 2026, 59(6): 519-528. |
| [6] | Li Wei¹, Yao Xu². Research on atopic dermatitis in China: current status and future perspectives [J]. Chinese Journal of Dermatology, 2026, 59(6): 505-511. |
| [7] | Blistering Diseases Research Group, China “Belt and Road” Dermatology Alliance, Collaborative Group on Pemphigus/Bullous Pemphigoid Research, Chinese Society of Dermatology. Expert consensus on the diagnosis and treatment of anti-p200 pemphigoid (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 387-395. |
| [8] | Pediatric Dermatology Group, Professional Committee of Pediatric Allergy, China Maternal and Child Health Association. Chinese expert consensus on the diagnosis and management of pediatric anogenital lichen sclerosus (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 396-406. |
| [9] | Cui Ruoran, Ning Xiaoli, Yang Jungang, Li Chengxu, Chang Jianmin, Chen Yudi. Evaluation of the diagnostic value of reflectance confocal microscopy combined with dermoscopy for basal cell carcinoma [J]. Chinese Journal of Dermatology, 2026, 59(5): 436-442. |
| [10] | Yang Jianqiu, Zhou Shengru, Zhou Qianqian, Yang Yifan, Li Min. Mutation analysis of the COL5A1 gene in a case of classical Ehlers-Danlos syndrome [J]. Chinese Journal of Dermatology, 2026, 59(5): 455-458. |
| [11] | Xu Zhuohong, Zhou Huan, Hu Yu, Gu Heng. Balneotherapy in skin diseases [J]. Chinese Journal of Dermatology, 2026, 59(5): 482-485. |
| [12] | Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology. Expert consensus on the diagnosis, treatment and rehabilitation of psoriasis in the elderly (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 407-418. |
| [13] | Hair Disease Rehabilitation Group, Chinese Association of Rehabilitation Dermatology, Hair Medicine Branch, Beijing Association of Holistic Integrative Medicine, Hair Research Group, Chinese Society of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases. Chinese expert consensus on hair biopsy and pathology (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 419-426. |
| [14] | Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on fecal microbiota transplantation in the treatment of psoriasis (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 427-435. |
| [15] | Chen Xue, Zhang Jianzhong. Chronic hand eczema: epidemiology, disease burden, pathogenesis, and management [J]. Chinese Journal of Dermatology, 2026, 59(4): 327-332. |
|